Digital Health Technology AbClon and TCT Health Technology Ink Exclusive CAR-T Therapy Deal for Turkish MarketMarch 4, 2025 AbClon has signed an exclusive technology transfer agreement with TCT Health Technology, a Turkish company, for its CAR-T cell therapy, AT101. The deal grants TCT exclusive rights in Turkey and includes upfront and milestone payments for AbClon.
